RBC Capital Maintains Sector Perform on Intercept Pharmaceuticals, Raises Price Target to $18

RBC Capital analyst Brian Abrahams maintains Intercept Pharmaceuticals (NASDAQ:ICPT) with a Sector Perform and raises the price target from $15 to $18.

RBC Capital analyst Brian Abrahams maintains Intercept Pharmaceuticals (NASDAQ:ICPT) with a Sector Perform and raises the price target from $15 to $18.

Total
0
Shares
Related Posts